Founder & CEO · Profluent · San Francisco, California, United States
Fresh capital means vendor and tool decisions are happening right now.
Open roles signal budget is being allocated across the org.
Most founders lock in key vendors within 60 days of closing a round.
The next frontier is authoring new biology, and with AI, we have the power to write the future—creating solutions that transform medicine, agriculture, and beyond.
